Clinical Study of Inhaled GB002 for Treatment of WHO Group I Pulmonary Arterial Hypertension
Clinical trial NCT03926793 · COMPLETED
Trial details
- NCT number
- NCT03926793
- Sponsor
- GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-04
- Primary completion
- 2021-05-05
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.